Inhibition of orf virus replication in goat skin fibroblast cells by the HSPA1B protein, as demonstrated by iTRAQ-based quantitative proteome analysis

Jun-hong Hao,Han-jin Kong,Ming-hao Yan,Chao-chao Shen,Guo-wei Xu,Da-jun Zhang,Ke-shan Zhang,Hai-xue Zheng,Xiang-tao Liu
DOI: https://doi.org/10.1007/s00705-020-04789-y
IF: 2.685
2020-09-02
Archives of Virology
Abstract:Orf virus (ORFV) infects sheep and goat tissues, resulting in severe proliferative lesions. To analyze cellular protein expression in ORFV-infected goat skin fibroblast (GSF) cells, we used two-dimensional liquid chromatography-tandem mass spectrometry coupled with isobaric tags for relative and absolute quantification (iTRAQ). The proteomics approach was used along with quantitative reverse transcription polymerase chain reaction (RT-qPCR) to detect differentially expressed proteins in ORFV-infected GSF cells and mock-infected GSF cells. A total of 282 differentially expressed proteins were identified. It was found that 222 host proteins were upregulated and 60 were downregulated following viral infection. We confirmed that these proteins were differentially expressed and found that heat shock 70-kDa protein 1B (HSPA1B) was differentially expressed and localized in the cytoplasm. It was also noted that HSPA1B caused inhibition of viral proliferation, in the middle and late stages of viral infection. The differentially expressed proteins were associated with the biological processes of viral binding, cell structure, signal transduction, cell adhesion, and cell proliferation.
virology
What problem does this paper attempt to address?
The problem this paper attempts to address is the study of changes in cellular protein expression in goat skin fibroblasts (GSF) after infection with orf virus (ORFV) using proteomics methods, and the exploration of the role of heat shock protein 70 kDa 1B (HSPA1B) in inhibiting ORFV replication. Specifically, the main objectives of the paper include: 1. **Analyzing changes in protein expression in GSF cells after ORFV infection**: Using iTRAQ technology combined with two-dimensional liquid chromatography-tandem mass spectrometry (2D LC-MS/MS) quantitative analysis to identify differentially expressed proteins. 2. **Confirming the function of differentially expressed proteins**: Verifying the differential expression of these proteins through methods such as quantitative reverse transcription polymerase chain reaction (RT-qPCR) and further analyzing their functions. 3. **Studying the role of HSPA1B in inhibiting ORFV replication**: Experimentally verifying the inhibitory effect of HSPA1B on viral proliferation during the mid and late stages of viral infection. These research results help to understand the response mechanisms of host cells during ORFV infection, particularly the potential role of HSPA1B in the antiviral process, providing a theoretical basis for the future development of new antiviral strategies.